EFFECT OF ECE AND NEP INHIBITION ON CIGARETTE SMOKE-INDUCED CELL PROLIFERATION IN THE RAT LUNG

REFERENCES

• Adachi, C., Naruse, M., Ishira, Y., Tanabe, A., Takagi, S., Yoshimoto, T., Naruse, K., Kagawa, J., and Takano, K. 2000. Effects of acute and chronic cigarette smoking on the expression of ET-1 mRNA of the cardiovascular tissues in rats. J. Cardiovasc. Pharmacol. 36:5198–5200.
   Web of Science ®Google Scholar
• Battistini, B., and Warner, T. D. 1997. Endothelin-induced responses in the pulmonary system. In Endothelins in biology and medicine, eds. J. P. Huggins and J. T. Pelton, pp. 191-222. New York: CRC Press.
   Google Scholar
• Battistini, B., Chaillier, P., D'Orleans-Juste, P., Briere, N., and Sirois, P. 1993. Growth regulatory properties of endothelins. Peptides 14:385–399.
   PubMed Web of Science ®Google Scholar
• Bobik, A., Grooms, A., Millar, J. A., Mitchell, A., and Grinpukel, S. 1990. Growth factor activity of endothelin on vascular smooth muscle. Am. J. PhysioL 258:C408–C415.
   PubMed Web of Science ®Google Scholar
• Brown, B., Kolesar, J., Lindberg, K., Meckley, D., Mosberg, A., and Doolittle, D. 1998. Comparative studies of DNA adduct formation in mice following dermal application of smoke condensates from cigarettes that burn or primarily heat tobacco. Mutat. Res. 414:21–30.
   PubMed Web of Science ®Google Scholar
• Caner, H. H., Kwan, A. L., Arthur, A., Jeng, A. Y., Lappe, R. W., Kassell, N. F., and Lee, K. S. 1996. Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage. J. Neurosurg. 85:917–922.
   PubMed Web of Science ®Google Scholar
• Carratu, P., Scuri, M., Styblo, J. L., Wanner, A., and Glassberg, M. K. 1997. ET-1 induces mitogenesis in ovine airway smooth muscle cells via ETA and ETB receptors. Am. J. Physiol. 272:L1021–L1024.
   PubMed Web of Science ®Google Scholar
• Dadmanesh, F., and Wright, J. L. 1997. Endothelin-A receptor antagonist BQ-610 blocks cigarette smoke-induced mitogenesis in rat airways and vessels. Am. J. PhysioL 272:L61 44618.
   Google Scholar
• De Lombaert, S., Ghai, R. D., Jeng, A. Y., Trapani, A. J., and Webb, R. L. 1994. Pharmacological pro-file of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-ccnverting enzyme. Biochem. Biophys. Res. Commun. 204:407–412.
   Google Scholar
• De Lombaert, S., Blanchard, L., Berry, C., Ghai, R. D., and Trapani, A. J. 1995a. Non-peptidic inhibitors of neutral endopeptidase 24.11. Bioorg. Med. Chem. Lett. 5:151–154.
   Google Scholar
• De Lombaert, S., Blanchard, L., Tan, J., Sakane, Y., Berry, C., and Ghai, R. D. 1995b. Non-peptidic inhibitors of neutral endopeptidase 24.11. Discovery and optimization of potency. Bioorg. Med. Chem. Lett. 5:145–150.
   Web of Science ®Google Scholar
• Di Maria, G. U., Bellofiore, S., and Geppetti, P. 1998. Regulation of airway neurogenic inflammation by neutral endopeptidase. Eur. Respir. J. 12:1454–1462.
   PubMed Web of Science ®Google Scholar
• Dinh-Xuan, A. T., Higenbottam, T. W., Clelland, C. A., Pepke-Zaba, J., Cremona, G., Butt, A. Y., Large, S. R., Wells, F. C., and Wallwork, J. 1991. Impairment of endothelium-dependent pul-monary-artery relaxation in chronic obstructive lung disease. N. Engl. J. Med. 324: 1539–1547.
   Google Scholar
• Dinh-Xuan, A. T., Pepke-Zaba, J., Butt, A. Y., Cremona, G., and Higenbottam, T. W. 1993. Impairment of pulmonary-artery endothelium-dependent relaxation in chronic obstructive lung disease is not due to dysfunction of endothelial cell membrane receptors nor to Larginine defi-ciency. Br. J. Pharmacol. 109: 587–591.
   Google Scholar
• Drexler, H., and Hornig, B. 1999. Endothelial dysfunction in human disease. J. Mol. Cell. Card ioL 31: 51–60.
   PubMed Web of Science ®Google Scholar
• Frasch, H. F., Marshall, C., and Marshall, B. E. 1999. Endothelin-1 is elevated in monocrotaline pul-monary hypertension. Am. J. PhysioL 276:L304–L310.
   Google Scholar
• Giaid, A., Yanagisawa, M., Langleben, D., Michel, R. P., Levy, R., Shennib, H., Kimura, S., Masaki, T., Duguid, W. P., and Stewart, D. J. 1993. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 328:1732–1739.
   PubMed Web of Science ®Google Scholar
• Glassberg, M. K., Ergul, A., Wanner, A., and Puett, D. 1994. Endothelin-1 promotes mitogenesis in airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 10:316–321.
   PubMed Web of Science ®Google Scholar
• Hale, K. A., Niewoehner, D. E., and Cosio, M. G. 1980. Morphologic changes in the muscular pul-monary arteries: Relationship to cigarette smoking, airway disease, and emphysema. Am. Rev. Respir. Dis. 122:273–278.
   PubMed Web of Science ®Google Scholar
• Kim, H., Yung, G. L., Morris, T. A., Marsh, J. J., Chiles, P. G., Pedersen, C. A., Konopka, R. G., and Channick, R. N. 1999a. Endothelin antagonism inhibits pulmonary vascular remodeling in canine chronic pulmonary embolism. Am. Rev. Respir. Crit. Care Med. 159:A566.
   Google Scholar
• Kim, H., Yung, G. L., Morris, T. A., Marsh, J. J., Chiles, P. G., Pedersen, C. A., Konopka, R. G., and Channick, R. N. 1999b. Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase. Am. Rev. Respir. Crit. Care Med. 159:A566.
   Google Scholar
• Kuwano, K., Bosken, C. H., Pare, P. D., Bai, T. R., Wiggs, B. R., and Hogg, J. C. 1993. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 148: 1220–1225.
   PubMed Web of Science ®Google Scholar
• Langston, C., Waszkiewicz, E., and Thurlbeck, W. M. 1979. A simple method for the representative sampling of lungs of diverse size. Thorax 34:527–530.
   PubMed Web of Science ®Google Scholar
• Maguire, J. J., Johnson, C. M., Mockridge, J. W., and Davenport, A. P. 1997. Endothelin converting enzyme (ECE) activity in human vascular smooth muscle. Br. J. Pharmacol. 122:1647–1654.
   PubMed Web of Science ®Google Scholar
• McVeigh, G. E., Lemary, L., Morgan, D., and Cohn, J. N. 1996. Effects of long-term cigarette smoking on endothelium-dependent responses in humans. Am. J. CardioL 78:668–672.
   PubMed Web of Science ®Google Scholar
• Noguchi, S., and Kashihara, Y. 1996. Structure in endothelin-1 infused guinea pigs in vivo. Am. Rev. Respir. Crit. Care Med. 153:A843–A843.
   Google Scholar
• Ohlstein, E. H., Arleth, A., Bryan, H., Elliott, J. D., and Sung, C. P. 1992. The selective endothel in ET, receptor antagonist BQ123 antagonizes endothelin-1-mediated mitogenesis. Eur. J. Pharmacol. Mol. Pharmaco/.225:347–350.
   PubMed Web of Science ®Google Scholar
• Opgenorth, T. J., Wu-Wong, J. R., and Shiosaki, K. 1992. Endothelin-ccnverting enzymes. FASEB J. 6: 2653–2659.
   Google Scholar
• Pare, P. D., Wiggs, B. R., James, A., Hogg, J. C., and Bosken, C. H. 1991. The comparative mechan-ics and morphology of airways in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 143:1189–1193.
   PubMedGoogle Scholar
• Peinado, V. I., Barbera, J. A., Ramirez, J., Gomez, F. P., Roca, J., Jover, L., Gimferrer, J. M., and Rodriquez-Roisin, R. 1998. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am. J. PhysioL 274:L908–L913.
   Google Scholar
• Roux, S., Breu, V., Ertel, S. I., and Clozel, M. 1999. Endothelin antagonism with bosentan: A review of potential applications. J. MoL Med. 77:364–376.
   PubMed Web of Science ®Google Scholar
• Sakurai, T., Yanagisawa, M., and Masaki, T. 1992. Molecular characterization of endothelin recep-tors. Trends PharmacoL Sci. 13:103–108.
   PubMed Web of Science ®Google Scholar
• Schiffrin, E. L. 1994. The endothelium and control of blood vessel function in health and disease. Clin. Invest. Med. 17:602–620.
   PubMed Web of Science ®Google Scholar
• Sekhon, H. S., Wright, J. L., and Churg, A. 1994. Cigarette smoke causes rapid cell proliferation in small airways and associated pulmonary arteries. Am. J. PhysioL 267:L557–L563.
   Google Scholar
• Stelzner, T. J., O'Brien, R. F., Yanagisawa, M., Sakurai, T., Sato, K., Webb, S., Zamora, M., McMurtry, I. F., and Fisher, J. H. 1992. Increased lung endothelin-1 production in rats with idiopathic pul-monary hypertension. Am. J. PhysioL 262 [6144620.
   Google Scholar
• Turner, A. J., and Tanzawa, K. 1997. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J. 11:355–364.
   PubMed Web of Science ®Google Scholar
• Vitalis, T. Z., Kern, I., Croome, A., Behzad, H., Hayashi, S., and Hogg, J. C. 1998. The effect of latent adenovirus 5 infection on cigarette smoke-induced lung inflammation. Eur. Respir. J. 11:664–669.
   PubMed Web of Science ®Google Scholar
• Wilson, G. D., Saunders, M. I., Dische, S., Daley, F. M., Robinson, B. M., Martindale, C. A., Joiner, B., and Richman, P. I. 1996. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours. Cell Proliferation 29:141–152.
   PubMed Web of Science ®Google Scholar
• Winter, R. J. D., Zhao, L., Krausz, T., and Hughes, J. M. B. 1991. Neutral endopeptidase 24.11 inhi-bition reduces pulmonary vascular remodeling in rats exposed to chronic hypoxia. Am. Rev. Respir. Dis. 144:1342–1346.
   PubMedGoogle Scholar
• Wright, J. L. 1993. The relationship of increased pulmonary artery pressure and airflow obstruction to emphysema.J. App/. PhysioL 74:1320–1324.
   PubMed Web of Science ®Google Scholar
• Wright, J. L., and Churg, A. 1991. Effect of long-term cigarette smoke exposure on pulmonary vascu-lar structure and function in the guinea pig. Exp. Lung Res. 17:997–1009.
   PubMed Web of Science ®Google Scholar
• Wright, J. L., and Sun, J.-P. 1994. The effect of smoking cessation on pulmonary and cardiovascular function and structure. J. App/. Physiol. 76: 2163–2168.
   Google Scholar
• Wright, J. L., and Sun, J.-P. 1999. Dissociation of chronic vascular cell proliferation and vascular contractility after chronic cigarette smoke exposure. Eur. Respir. J. 14: 832–838.
   Google Scholar
• Wright, J. L., Sun, J.-P., and Churg, A. 1998. Glutathione levels play a role in cigarette smoke induced cell proliferation in the rat lung. InhaL ToxicoL 10:969–994.
   Web of Science ®Google Scholar
• Wyatt, T. A., Schmidt, S. C., Rennard, S. I., Tuma, D. J., and Sisson, J. H. 2000. Acetaldehyde-stimu-lated PKC activity in airway epithelial cells treated with smoke extract from normal and smoke-less cigarettes. Proc. Soc. Exp. Biol. Med. 225:91–97.
   PubMed Web of Science ®Google Scholar
• Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayahi, M., Mitsui, Y., Yazaki, Y., Goto, K., and Masaki, T. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415.
   PubMed Web of Science ®Google Scholar
• Yang, Q., Battistini, B., D'Orleans-Juste, P., Jeng, A. Y., and Sirois, P. 1997. Modulation of endothelin production and metabolism in guinea-pig tracheal epithelial cells by peptidase inhibitors. Am. Rev. Respir. Dis. 155: 1884–1889.
   Google Scholar
• Yildiz, L., Akcay, F., Kaynar, H., and Bakan, N. 1996. Increased plasma endothelin-1 in heavy and light smokers. Clin. Chem. 42:483–484.
   PubMed Web of Science ®Google Scholar